Xcell Therapeutics Inc. (KOSDAQ:373110)
South Korea
· Delayed Price · Currency is KRW 3,820.00
-25.00 (-0.65%)
May 14, 2025, 9:39 AM KST
Xcell Therapeutics Market Cap
Xcell Therapeutics has a market cap or net worth of 42.06 billion as of May 13, 2025.
Market Cap
42.06B
Enterprise Value
38.96B
Revenue
1.93B
Ranking
n/a
PE Ratio
n/a
Stock Price
3,820.00
Market Cap Chart
Since July 15, 2024, Xcell Therapeutics's market cap has decreased from 90.22B to 42.06B, a decrease of -53.38%. That is a compound annual growth rate of -60.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2025 | 42.06B | -5.24% |
| Dec 30, 2024 | 44.38B | -50.80% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 74.02T |
| Celltrion | 33.69T |
| ALTEOGEN | 18.39T |
| Yuhan | 8,026.78B |
| HLB Co., Ltd. | 7,581.42B |
| SK Biopharmaceuticals | 7,079.52B |
| PharmaResearch | 4,171.44B |
| Peptron | 3,872.02B |